Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Swaratika Majumdar, Neha Sharma, Manju Sengar, Jayashree Thorat, Lingaraj Nayak, Avinash Bonda, Bhausaheb Bagal, Akhil Rajendra, Amit Sethi & Hasmukh Jain. (2023) A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome. Leukemia & Lymphoma 64:3, pages 628-638.
Read now
Read now
Heather P. May, Kristin C. Mara, Erin F. Barreto, Nelson Leung & Thomas M. Habermann. (2021) Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome. Leukemia & Lymphoma 62:13, pages 3152-3159.
Read now
Read now
Nael Alakel, Jan Moritz Middeke, Johannes Schetelig & Martin Bornhäuser. (2017) Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. OncoTargets and Therapy 10, pages 597-605.
Read now
Read now
M. Criscuolo, L. Fianchi, G. Dragonetti & L. Pagano. (2016) Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency. Expert Review of Hematology 9:2, pages 197-208.
Read now
Read now
Jennifer Dinnel, Bonny L Moore, Brent M Skiver & Prithviraj Bose. (2015) Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy. Core Evidence 10, pages 23-38.
Read now
Read now
Kenji Kishimoto, Ryoji Kobayashi, Mizuho Ichikawa, Hirozumi Sano, Daisuke Suzuki, Kazue Yasuda, Akihiro Iguchi & Kunihiko Kobayashi. (2015) Risk factors for tumor lysis syndrome in childhood acute myeloid leukemia treated with a uniform protocol without rasburicase prophylaxis. Leukemia & Lymphoma 56:7, pages 2193-2195.
Read now
Read now
Emmanuel Canet, Morgane Cheminant, Lara Zafrani, Catherine Thieblemont, Lionel Galicier, Etienne Lengline, David Schnell, Danielle Reuter, Michael Darmon, Benoit Schlemmer & Elie Azoulay. (2014) Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?. Leukemia & Lymphoma 55:10, pages 2362-2367.
Read now
Read now
Yoko Oka, Haruko Tashiro, Ryosuke Sirasaki, Tadashi Yamamoto, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji & Shin Fujimori. (2014) Hyperuricemia in Hematologic Malignancies Is Caused by an Insufficient Urinary Excretion. Nucleosides, Nucleotides & Nucleic Acids 33:4-6, pages 434-438.
Read now
Read now
Belal M. Firwana, Rim Hasan, Nour Hasan, Fares Alahdab, Iyad Alnahhas, Seba Hasan & Joseph Varon. (2012) Tumor Lysis Syndrome: A Systematic Review of Case Series and Case Reports. Postgraduate Medicine 124:2, pages 92-101.
Read now
Read now
Giulia Malaguarnera, Maria Giordano & Mariano Malaguarnera. (2012) Rasburicase for the treatment of tumor lysis in hematological malignancies. Expert Review of Hematology 5:1, pages 27-38.
Read now
Read now
Masaru Kubota, Ayako Nagai, Li Tang & Masakuni Tokuda. (2011) Investigation on Hyperuricemia in Children with Obesity or Various Pediatric Disorders. Nucleosides, Nucleotides & Nucleic Acids 30:12, pages 1051-1059.
Read now
Read now
Ayako Nagai, Masaru Kubota, Li Tang, Souichi Adachi, Ikuya Usami & Kousaku Matsubara. (2011) Hyperuricemia in Pediatric Malignancies Before Treatment. Nucleosides, Nucleotides & Nucleic Acids 30:12, pages 1060-1065.
Read now
Read now
Michael Darmon, Isabelle Guichard, François Vincent, Benoit Schlemmer & Élie Azoulay. (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leukemia & Lymphoma 51:2, pages 221-227.
Read now
Read now
Andrea Pession, Fraia Melchionda & Claudia Castellini. (2008) Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). Biologics: Targets and Therapy 2:1, pages 129-141.
Read now
Read now
Jessica Hochberg & Mitchell S Cairo. (2008) Rasburicase: future directions in tumor lysis management. Expert Opinion on Biological Therapy 8:10, pages 1595-1604.
Read now
Read now
Bertrand Coiffier & Catherine Riouffol. (2007) Management of tumor lysis syndrome in adults. Expert Review of Anticancer Therapy 7:2, pages 233-239.
Read now
Read now
Anthony R. Mato, Brett E. Riccio, Li Qin, Daniel F. Heitjan, Martin Carroll, Alison Loren, David L. Porter, Alexander Perl, Edward Stadtmauer, Donald Tsai, Alan Gewirtz & Selina M. Luger. (2006) A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leukemia & Lymphoma 47:5, pages 877-883.
Read now
Read now
Samin Alavi, Mohammad Taghi Arzanian, Mohammad Reza Abbasian & Zahra Ashena. (2006) TUMOR LYSIS SYNDROME IN CHILDREN WITH NON-HODGKIN LYMPHOMA. Pediatric Hematology and Oncology 23:1, pages 65-70.
Read now
Read now
J.
M. de Bont & R. Pieters. (2004) Management of Hyperuricemia with Rasburicase Review. Nucleosides, Nucleotides & Nucleic Acids 23:8-9, pages 1431-1440.
Read now
Read now
Michel van Agthoven, Carin A Uyl-de Groot, Pieter Sonneveld & Anton Hagenbeek. (2004) Economic assessment in the management of non-Hodgkin’s lymphoma. Expert Opinion on Pharmacotherapy 5:12, pages 2529-2548.
Read now
Read now
Articles from other publishers (90)
Tianyou Wang, Xiaofan Zhu, Yumei Chen, Shuhong Shen, Yongmin Tang, Jingying Zhang, Yingyi He, Hui Zhang, Ju Gao, Jianpei Fang, Rong Liu, Xiaoyan Wu, Jinchuan Sun & Minlu Zhang. (2023) Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study. Drugs in R&D 23:2, pages 129-140.
Crossref
Crossref
Ebellins Tabares Calvache, Allison Dessiret Tabares Calvache & Cristiane Seganfredo Weber. (2023) Tumor lysis syndrome in hematological inpatients, experience from a university hospital in Brazil: A retrospective cohort study. Hematology, Transfusion and Cell Therapy.
Crossref
Crossref
Robert Chapman, Sita Shah & Alberto D’Angelo. (2022) Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care. Journal of the Intensive Care Society 24:1, pages 112-116.
Crossref
Crossref
Bohdan Baralo, Nithya Ramesh, Sohiel Deshpande, Bhanusowymya C Buragamadagu, Aliza Khanam, Mahati Paravathaneni, Sana Mulla, Verushka Bedi, Vihitha Thota, Raisa Baralo, Akhil Jain, Eugene Choi & Rajesh Thirumaran. (2023) Review of Hematology-Oncology Emergencies for Internal Medicine Residents. Cureus.
Crossref
Crossref
Kerry A RogersXiaoxiao LuBruno EmondAurélie Côté-SergentFrédéric KinkeadMarie-Hélène LafeuillePatrick LefebvreQing Huang. (2022) Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study. Journal of Managed Care & Specialty Pharmacy 28:9, pages 1033-1045.
Crossref
Crossref
Gabriela Lupușoru, Ioana Ailincăi, Georgiana Frățilă, Oana Ungureanu, Andreea Andronesi, Mircea Lupușoru, Mihaela Banu, Ileana Văcăroiu, Constantin Dina & Ioanel Sinescu. (2022) Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology. Biomedicines 10:5, pages 1012.
Crossref
Crossref
Tarek Barbar & Insara Jaffer Sathick. (2021) Tumor Lysis Syndrome. Advances in Chronic Kidney Disease 28:5, pages 438-446.e1.
Crossref
Crossref
Jan Philipp Bewersdorf & Amer M. Zeidan. (2020) Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?. Cells 9:10, pages 2310.
Crossref
Crossref
Gang Liu, Xiaofeng Chen, Xiang Lu, Jiayuan Zhao & Xueli Li. (2020) Sunflower head enzymatic hydrolysate relives hyperuricemia by inhibiting crucial proteins (xanthine oxidase, adenosine deaminase, uric acid transporter1) and restoring gut microbiota in mice. Journal of Functional Foods 72, pages 104055.
Crossref
Crossref
Victoria Augustín Bandera, María Ángeles Villena-Ruiz, Francisco Granados Pacheco, Luis Robles Cabeza & Josefa Andrea Aguilar García. (2020) Síndrome de lisis tumoral espontáneo. Revista Española de Casos Clínicos en Medicina Interna 5:2.
Crossref
Crossref
Joanna Matuszkiewicz-Rowinska & Jolanta Malyszko. (2020) Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress. Kidney and Blood Pressure Research 45:5, pages 645-660.
Crossref
Crossref
MANDANA RASTEGAR, ABHIJAT KITCHLU & ANUSHREE C. SHIRALI. 2020. Onco-Nephrology. Onco-Nephrology
275
280.e3
.
O’Dene Lewis & Stephen M. Pastores. 2020. Oncologic Critical Care. Oncologic Critical Care
1119
1133
.
Jose Manuel Calvo Villas. (2019) Síndrome de lisis tumoral. Medicina Clínica 152:10, pages 397-404.
Crossref
Crossref
Jose Manuel Calvo Villas. (2019) Tumour lysis syndrome. Medicina Clínica (English Edition) 152:10, pages 397-404.
Crossref
Crossref
Phyo Thazin Myint, Hifza Waheed Butt, Taha Alrifai & Carlos Marin. (2019) Spontaneous Tumor Lysis Syndrome Secondary to Small-Cell Neuroendocrine Carcinoma of Unknown Origin: A Rare Case Report and Literature Review. Case Reports in Oncological Medicine 2019, pages 1-6.
Crossref
Crossref
Can Hüzmeli. (2019) Assessment of tumor lysis syndrome cases. Cumhuriyet Medical Journal.
Crossref
Crossref
Shelly M. WilliamsAnthony A. Killeen. (2018) Tumor Lysis Syndrome. Archives of Pathology & Laboratory Medicine 143:3, pages 386-393.
Crossref
Crossref
O’Dene Lewis & Stephen M. Pastores. 2019. Oncologic Critical Care. Oncologic Critical Care
1
15
.
Lauren Pommert, Steven Margossian & Michael Burke. 2019. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient
9
28
.
Kaduveettil Gopinathan Gopakumar, Shwetha Seetharam, Jagathnath Krishna KM, Manjusha Nair, Binitha Rajeswari, Guruprasad CS, Prasanth VR & Priyakumari Thankamony. (2018) Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting. Pediatric Blood & Cancer 65:12, pages e27401.
Crossref
Crossref
Morné F. Kahts, Alan Davidson, Ann Van Eyssen, Peter Nourse, Mignon McCulloch & Marc Hendricks. (2018) A cost comparison of rasburicase versus dialysis in the management of children with acute leukaemia and lymphoma at a South African centre. South African Journal of Oncology 2.
Crossref
Crossref
Jieyun Xia, Haiying Sun, Zhiling Yan, Feng Zhu, Kai Zhao & Kailin Xu. (2018) Successful treatment of a patient with Philadelphia chromosome‑positive acute lymphoblastic leukemia complicated by bone marrow necrosis and acute renal insufficiency: A case report. Molecular and Clinical Oncology.
Crossref
Crossref
Suhail A Shaikh, Bernard L Marini, Shannon M Hough & Anthony J Perissinotti. (2017) Rational use of rasburicase for the treatment and management of tumor lysis syndrome. Journal of Oncology Pharmacy Practice 24:3, pages 176-184.
Crossref
Crossref
Jonathan Wagner & Sanjay Arora. (2017) Oncologic Metabolic Emergencies. Hematology/Oncology Clinics of North America 31:6, pages 941-957.
Crossref
Crossref
Young-Woo Jeon, Dae-Hun Kwak, Sung-Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Jong-Wook Lee, Woo-Sung Min & Seok-Goo Cho. (2017) Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome. Clinical Lymphoma Myeloma and Leukemia 17:9, pages 595-603.
Crossref
Crossref
A.-S. Vasseur & A.-S. Moreau. (2017) Analyse et critique des recommandations britanniques 2015 de prise en charge du syndrome de lyse tumorale de l’adulteAnalysis of the British guidelines 2015 for the management of adult tumor lysis syndrome. Médecine Intensive Réanimation.
Crossref
Crossref
Sean Stuart & Jonathan Auten. (2017) A rare seizure: Tumor lysis syndrome after radiation therapy of a solid tumor. The American Journal of Emergency Medicine 35:6, pages 941.e3-941.e4.
Crossref
Crossref
Thorvardur R. Halfdanarson, William J. Hogan & Bo E. Madsen. (2017) Emergencies in Hematology and Oncology. Mayo Clinic Proceedings 92:4, pages 609-641.
Crossref
Crossref
Daniel KL Cheuk, Alan KS Chiang, Godfrey CF Chan & Shau Yin Ha. (2017) Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Mitchell S. Cairo, Stephen Thompson, Krishna Tangirala & Michael T. Eaddy. (2017) A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome. Clinical Lymphoma Myeloma and Leukemia 17:3, pages 173-178.
Crossref
Crossref
Raymond Farah & Moise Levovich. 2017. Complicated War Trauma and Care of the Wounded. Complicated War Trauma and Care of the Wounded
95
97
.
Leesha L. Barnese. (2016) Risk and prevention strategies can help avert tumor lysis syndrome. Pharmacy Today 22:7, pages 52-54.
Crossref
Crossref
Katherine L. Kunstel. (2016) Oncologic Emergencies. Physician Assistant Clinics 1:3, pages 397-408.
Crossref
Crossref
Christian Nusshag, Susanne Fink & Martin Zeier. (2016) Prophylaxe und Therapie des Tumorlysesyndroms. Im Focus Onkologie 19:7-8, pages 50-57.
Crossref
Crossref
Maya Kolin, Menachem Ben-Shahar, Olga Lapin & Hadassah Goldberg. (2016) Severe Tumor Lysis Syndrome in a Patient With Pancreatic Adenocarcinoma. Pancreas 45:4, pages e12-e13.
Crossref
Crossref
Koji Kimura, Naomi Kanehira, Risa Takayanagi, Hideto Minohara, Masato Homma & Yasuhiko Yamada. (2016) Prediction of Therapeutic Effect of Rasburicase on Hyperuricemia Associated with Chemotherapy Based on Theoretical Model. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:5, pages 705-711.
Crossref
Crossref
C. Nusshag, S. Fink & M. Zeier. (2015) Das TumorlysesyndromTumor lysis syndrome. Der Nephrologe 11:1, pages 6-13.
Crossref
Crossref
Gail L Jones, Andrew Will, Graham H Jackson, Nicholas J A Webb & Simon Rule. (2015) Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. British Journal of Haematology 169:5, pages 661-671.
Crossref
Crossref
G. A. Novichkova, V. V. Ptushkin & A. G. Rumyantsev. (2015) Clinical guidelines for the prevention and treatment of tumor lysis syndrome in children and adolescents. Russian Journal of Children Hematology and Oncology:1, pages 37-50.
Crossref
Crossref
Anne Marsh, Anurag K. Agrawal & James H. Feusner. 2015. Supportive Care in Pediatric Oncology. Supportive Care in Pediatric Oncology
45
58
.
Daniel KL Cheuk, Alan KS Chiang, Godfrey CF Chan & Shau Yin Ha. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Rebekah A. Burns, Irina Topoz & Sally L. Reynolds. (2014) Tumor Lysis Syndrome. Pediatric Emergency Care 30:8, pages 571-576.
Crossref
Crossref
Jonathan Wagner & Sanjay Arora. (2014) Oncologic Metabolic Emergencies. Emergency Medicine Clinics of North America 32:3, pages 509-525.
Crossref
Crossref
F. Perry Wilson & Jeffrey S. Berns. (2014) Tumor Lysis Syndrome: New Challenges and Recent Advances. Advances in Chronic Kidney Disease 21:1, pages 18-26.
Crossref
Crossref
Eric K. Judd, Shikha Mehta & Ashita J. Tolwani. 2013. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation
199
236
.
F. Perry Wilson & Jeffrey S. Berns. (2012) Onco-Nephrology. Clinical Journal of the American Society of Nephrology 7:10, pages 1730-1739.
Crossref
Crossref
Denish Mika, Sabrina Ahmad & C. Guruvayoorappan. (2012) Tumour Lysis Syndrome: Implications for Cancer Therapy. Asian Pacific Journal of Cancer Prevention 13:8, pages 3555-3560.
Crossref
Crossref
Randall W Knoebel, Mimi Lo & Christopher W Crank. (2010) Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome. Journal of Oncology Pharmacy Practice 17:3, pages 147-154.
Crossref
Crossref
Jamie L. Dargart & Nobuko Hijiya. (2011) Metabolic Emergencies in the Child With Acute Leukemia. Clinical Pediatric Emergency Medicine 12:3, pages 191-201.
Crossref
Crossref
Andrea Pession, Riccardo Masetti, Gianluca Gaidano, Patrizia Tosi, Giovanni Rosti, Massimo Aglietta, Giorgina Specchia, Fulvio Porta & Fabrizio Pane. (2011) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel. Advances in Therapy 28:8, pages 684-697.
Crossref
Crossref
Andrew Will & Eleni Tholouli. (2011) The clinical management of tumour lysis syndrome in haematological malignancies. British Journal of Haematology 154:1, pages 3-13.
Crossref
Crossref
P. Bose & O. Qubaiah. (2011) A review of tumour lysis syndrome with targeted therapies and the role of rasburicase. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 299-326.
Crossref
Crossref
G. Burghi, D. Berrutti & W. Manzanares. (2011) Síndrome de lisis tumoral en terapia intensiva: encare diagnóstico y terapéutico. Medicina Intensiva 35:3, pages 170-178.
Crossref
Crossref
Karen P. Seiter, Nicholas J. Sarlis & Edward S. Kim. (2011) Management of hyperuricemia in adults with or at risk of tumor lysis syndrome. Community Oncology 8:4, pages 163-170.
Crossref
Crossref
G. Burghi, D. Berrutti & W. Manzanares. (2011) Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare. Medicina Intensiva (English Edition) 35:3, pages 170-178.
Crossref
Crossref
Stefanie Froh. 2011. Die Intensivmedizin. Die Intensivmedizin
1095
1100
.
Michael Darmon, Laurent Camous, Camille Devanlay, Emmanuel Canet, Benoit Schlemmer & Fabrice Zeni. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies
637
650
.
Bob Phillips & Roderick Skinner. 2010. Pediatric Hematology and Oncology. Pediatric Hematology and Oncology
333
359
.
Daniel KL Cheuk, Alan KS Chiang, Godfrey CF Chan & Shau Yin Ha. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Mitchell S. Cairo, Bertrand Coiffier, Alfred Reiter & Anas Younes. (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. British Journal of Haematology 149:4, pages 578-586.
Crossref
Crossref
Ali K. Abu-Alfa & Anas Younes. (2010) Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management. American Journal of Kidney Diseases 55:5, pages S1-S13.
Crossref
Crossref
Tariq I. Mughal, A. Ahsan Ejaz, John R. Foringer & Bertrand Coiffier. (2010) An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome. Cancer Treatment Reviews 36:2, pages 164-176.
Crossref
Crossref
Shayne Cox GadWayne Materi, Zoltan Gombos & David S. Wishart. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
T.R. Türk, M. Hörbelt & A. Kribben. (2010) Maligne Erkrankungen und NephropathieKidney disease and oncology. Der Nephrologe 5:1, pages 20-28.
Crossref
Crossref
Mark R. Zonfrillo. (2009) Management of Pediatric Tumor Lysis Syndrome in the Emergency Department. Emergency Medicine Clinics of North America 27:3, pages 497-504.
Crossref
Crossref
Yoshiyuki Nakamura, Yasuhiro Nakamura, Enmi Hori, Junichi Furuta, Yoshiyuki Ishii, Takenori Takahashi, Yasuhiro Kawachi & Fujio Otsuka. (2009) Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. International Journal of Dermatology 48:7, pages 763-767.
Crossref
Crossref
Kyung A. Choi, Jung Eun Lee, Yoon-Goo Kim, Dae Joong Kim, Kihyun Kim, Young Hyeh Ko, Ha Young Oh, Won Seog Kim & Wooseong Huh. (2008) Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Annals of Hematology 88:7, pages 639-645.
Crossref
Crossref
J. Ritter. (2009) Tumorlysesyndrom. best practice onkologie 4:3, pages 38-45.
Crossref
Crossref
Kenichi Ishizawa, Michinori Ogura, Motohiro Hamaguchi, Tomomitsu Hotta, Kazunori Ohnishi, Tsuneo Sasaki, Hisashi Sakamaki, Hisayuki Yokoyama, Hideo Harigae & Yasuo Morishima. (2009) Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study. Cancer Science 100:2, pages 357-362.
Crossref
Crossref
Elizabeth Mullen, Jennifer Whangbo & Lynda M. Vrooman. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
1121
1143
.
M. Darmon, M. Roumier & E. Azoulay. 2009. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine
819
827
.
J. D'Orazio. 2009. Pediatric Nephrology in the ICU. Pediatric Nephrology in the ICU
201
218
.
M. Darmon, M. Roumier & E. Azoulay. 2009. Intensive Care Medicine. Intensive Care Medicine
819
827
.
Bertrand Coiffier, Arnold Altman, Ching-Hon Pui, Anas Younes & Mitchell S. Cairo. (2008) Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review. Journal of Clinical Oncology 26:16, pages 2767-2778.
Crossref
Crossref
Yves Bertrand, Françoise Mechinaud, Benoit Brethon, Valerie Mialou, Anne Auvrignon, Brigitte Nelken, Anne Notz-Carrère, Dominique Plantaz, Catherine Patte, Marisol Urbieta, André Baruchel & Guy Leverger. (2008) SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) Recommendations for the Management of Tumor Lysis Syndrome (TLS) With Rasburicase: An Observational Survey. Journal of Pediatric Hematology/Oncology 30:4, pages 267-271.
Crossref
Crossref
Sean Candrilli, Timothy Bell, William Irish, Erin Morris, Stanton Goldman & Mitchell S. Cairo. (2008) A Comparison of Inpatient Length of Stay and Costs Among Patients with Hematologic Malignancies (Excluding Hodgkin Disease) Associated with and Without Acute Renal Failure. Clinical Lymphoma and Myeloma 8:1, pages 44-51.
Crossref
Crossref
Daniel KL Cheuk, Alan KS Chiang, Godfrey CF Chan & Shau Yin Ha. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jessica Hochberg, Mitchell S. Cairo & Peter F. Coccia. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
759
765
.
Ridvan Ali, Fahir Ozkalemkas, Atilla Ozkan, Tulay Ozcelik, Vildan Ozkocaman, Ibrahim Akdag, Ulku Ozan & Ahmet Tunali. (2007) Tumour lysis syndrome with acute renal failure during imatinib therapy. Leukemia Research 31:4, pages 573-574.
Crossref
Crossref
Amy R. Sood, Lisa D. Burry & Doret K. F. Cheng. (2012) Clarifying the Role of Rasburicase in Tumor Lysis Syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:1, pages 111-121.
Crossref
Crossref
C. Gemici. (2006) Tumour Lysis Syndrome in Solid Tumours. Clinical Oncology 18:10, pages 773-780.
Crossref
Crossref
A. Ozkan, B. Hakyemez, F. Ozkalemkas, R. Ali, V. Ozkocaman, T. Ozcelik, O. Taskapilioglu, Y. Altundal & A. Tunali. (2006) Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology 48:12, pages 887-892.
Crossref
Crossref
Zekai Avci, Bulent Alioglu, Oguz Canan, Figen Özcay, Bulent Celasun, Faik Sarialioglu & Namik Ozbek. (2006) Calcification of the Gastric Mucosa Associated With Tumor Lysis Syndrome in a Child With Non-Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology 28:5, pages 307-310.
Crossref
Crossref
Donald A Hutcherson, David C Gammon, Mansi S Bhatt & Melissa Faneuf. (2006) Reduced-Dose Rasburicase in the Treatment of Adults with Hyperuricemia Associated with Malignancy. Pharmacotherapy 26:2, pages 242-247.
Crossref
Crossref
Duk-Joo LeeChi-Un ChoiChung-Sik LeeHak-Hyun LeeJin-Kyu ParkJung-Hye ChoiYoung-Yeul LeeIn-Soon Kim. (2006) Tumor Lysis Syndrome in Lymphoblastic Crisis of CML. The Korean Journal of Hematology 41:2, pages 119.
Crossref
Crossref
Martin L. Brecher & Joan Roberts. 2006. Pediatric Critical Care. Pediatric Critical Care
1173
1184
.
Asterios Karagiannis, Ioannis Tsorlalis, Anna Kakafika, Panagiotis Pateinakis, Vasilios Perifanis & Faidon Harsoulis. (2004) Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin?s lymphoma. Annals of Hematology 84:5, pages 343-346.
Crossref
Crossref
Anne-Sophie Michallet, Sophie Tartas & Bertrand Coiffier. (2005) Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic Malignancies. Supportive Cancer Therapy 2:3, pages 159-166.
Crossref
Crossref
Bertrand CoiffierNicolas MounierSerge BolognaChristophe FerméHervé TillyAnne SonetBernard ChristianOlivier CasasnovasEric JourdanKarim BelhadjRaoul Herbrecht. (2003) Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study. Journal of Clinical Oncology 21:23, pages 4402-4406.
Crossref
Crossref